The Generation of Dual-Targeting Fusion Protein PD-L1/CD47 for the Inhibition of Triple-Negative Breast Cancer

por Bian, Yanlin, Lin, Tong, Jakos, Tanja, Xiao, Xiaodong, Zhu, Jianwei
Publicado 2022

A Rational Designed Novel Bispecific Antibody for the Treatment of GBM

por Sun, Rui, Zhou, Yuexian, Han, Lei, Pan, Zhidi, Chen, Jie, Zong, Huifang, Bian, Yanlin, Jiang, Hua, Zhang, Baohong, Zhu, Jianwei
Publicado 2021

Binding domain on CD22 molecules contributing to the biological activity of T cell-engaging bispecific antibodies

por Chen, Jie, Pan, Zhidi, Han, Lei, Liu, Junjun, Yue, Yali, Xiao, Xiaodong, Zhang, Baohong, Wu, Mingyuan, Yuan, Yunsheng, Bian, Yanlin, Jiang, Hua, Xie, Yueqing, Zhu, Jianwei
Publicado 2023

Mutational escape prevention by combination of four neutralizing antibodies that target RBD conserved regions and stem helix

por Tang, Haoneng, Ke, Yong, Liao, Yunji, Bian, Yanlin, Yuan, Yunsheng, Wang, Ziqi, Yang, Li, Ma, Hang, Sun, Tao, Zhang, Baohong, Zhang, Xiaoju, Wu, Mingyuan, Zhu, Jianwei
Publicado 2022

Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBD

por Ma, Hang, Guo, Yingying, Tang, Haoneng, Tseng, Chien-Te K., Wang, Lei, Zong, Huifang, Wang, Zhenyu, He, Yang, Chang, Yunsong, Wang, Shusheng, Huang, Haiqiu, Ke, Yong, Yuan, Yunsheng, Wu, Mingyuan, Zhang, Yuanyuan, Drelich, Aleksandra, Kempaiah, Kempaiah Rayavara, Peng, Bi-Hung, Wang, Ailin, Yang, Kaiyong, Yin, Haiyang, Liu, Junjun, Yue, Yali, Xu, Wenbo, Zhu, Shuangli, Ji, Tianjiao, Zhang, Xiaoju, Wang, Ziqi, Li, Gang, Liu, Guangchun, Song, Jingjing, Mu, Lingling, Xiang, ZongShang, Song, Zhangyi, Chen, Hua, Bian, Yanlin, Zhang, Baohong, Chen, Hui, Zhang, Jiawei, Liao, Yunji, Zhang, Li, Yang, Li, Chen, Yi, Gilly, John, Xiao, Xiaodong, Han, Lei, Jiang, Hua, Xie, Yueqing, Zhou, Qiang, Zhu, Jianwei
Publicado 2022